SCHEMBL8560391

SCHEMBL8560391

CC(=O)NS(=O)(=O)c1cncs1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
DHFR P00374 1/20 0.40
TSHR P16473 1/20 0.40
ABCC9 O60706 1/20 0.39
ABCC8 Q09428 1/20 0.39
KCNJ11 Q14654 1/20 0.39
KCNJ8 Q15842 1/20 0.39
KAT7 O95251 1/20 0.37
KAT6A Q92794 1/20 0.37
KAT5 Q92993 1/20 0.37
KAT8 Q9H7Z6 1/20 0.37
PKM P14618 2/20 0.37
ALDH1A1 P00352 1/20 0.36
BRAF P15056 1/20 0.36
NAMPT P43490 1/20 0.36
POLB P06746 1/20 0.34
PTGS2 P35354 2/20 0.34
AKT1 P31749 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27785439 0.82 KAT7 (0.37) ABCC9ABCC8KCNJ11KCNJ8KAT7
SCHEMBL5654171 0.77 ABCC9 (0.37) SMN1; SMN2TSHRABCC9ABCC8KCNJ11
SCHEMBL4659266 0.73 ABCC9 (0.40) SMN1; SMN2ABCC9ABCC8KCNJ11KCNJ8
SCHEMBL5657468 0.73 ABCC9 (0.35) SMN1; SMN2ABCC9ABCC8KCNJ11KCNJ8
SCHEMBL14417207 0.69 CYP2D6 (0.55) TDP1TSHRPKMALDH1A1HTT
Hydrochloric Acid SCHEMBL27576989 0.69 HDAC8 (0.36) ABCC9ABCC8KCNJ11KCNJ8NAMPT
Fluoride SCHEMBL27814813 0.69 HDAC8 (0.36) ABCC9ABCC8KCNJ11KCNJ8KAT7
SCHEMBL6761611 0.66
SCHEMBL15577218 0.66
SCHEMBL15625520 0.65 MCL1 (0.45) KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0832076-A1 NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-04-01 EP disclosed
EP-0730590-A1 NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-09-11 EP disclosed